Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab

NCT06465433 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
25
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Incyte Corporation